top of page

Do You Have Acute COPD/Asthma?

Learn more about our clinical trials. Talk to your doctor to see if a clinical trial might be right for you or your loved one.

How do Clinical Trials Work?

A clinical trial studies a potential medicine to answer these key questions: 1) How safe is it? 2) Does it work? 3) Does it cause any side effects? If the new medicine is approved by regulators, a doctor can then prescribe it to treat a disease or condition.

Preclinical

Preclinical.png

Answers basic questions about an investigational medicine's safety. Lab and animal testing happen before starting clinical trials with people. 

Phase 1

Phase1.png

Studies the overall safety and treatment dose. Researchers study how the potential new medicine works in the body. People in this phase are often healthy volunteers, with no known major health concerns.

Phase 2

Phase2.png

Continues to study the safety of the potential medicine and the best dose. Researchers also study how it works and possible side effects.

Phase 3

Phase3.png

Studies the safety and effects of the potential medicine in a large group of people. It is often compared to a placebo, which has no active ingredients. It may also be compared to a "standard of care," which is the currently available treatment people typically receive. Or it may be compared to other treatments for the specific disease. 

Phase 4

Phase4.png

Studies the long-term risks and benefits of the new treatment. Phase 4 trials happen after the potential medicine is approved for use.

Trial Information

An acute exacerbation of asthma or chronic obstructive pulmonary disease (COPD) is a sudden, sustained worsening of respiratory symptoms—such as severe shortness of breath, coughing, wheezing, and changes in mucus production—that goes beyond normal day-to-day variations and requires extra medical treatment.

​

A Phase 2, open-label, single-arm trial to evaluate IV rademikibart as an add-on treatment for acute exacerbation in participants with asthma or COPD with type 2 inflammation.

​

For an overview of the Seabreeze STAT IV study, visit clinicaltrials.gov. 

​

​

Select Inclusion Criteria - Asthma

check.png

Age: 18 Years to 85 Years.

check.png

Physician-diagnosed asthma.

check.png

Current acute asthma exacerbation requiring an urgent healthcare visit for treatment.

check.png

Body weight of ≥40 kg and BMI ≤45 kg/m2 at SV1a.

check.png

Must have experienced at least 1 asthma exacerbation requiring the use of systemic corticosteroids.

check.png

Currently receiving treatment with low, medium, to high dose ICS in combination with at least 1 additional asthma controller medication.

Select Exclusion Criteria - Asthma

cross.png

Regular use of immunosuppressive medication.

cross.png

Female participant who is pregnant, lactating or breast-feeding.

cross.png

Current or former smoker, with a smoking history of ≥5 pack-years if <30 years old or ≥10 pack-years if ≥30 years old.

cross.png

COPD and other clinically significant pulmonary disease other than asthma.

cross.png

Unstable ischemic heart disease, cardiomyopathy, heart failure, uncontrolled hypertension.

cross.png

History of known immunodeficiency disorder or hepatitis B or C.

cross.png

History of alcohol abuse and/or drug abuse.

Criteria

Below are select criteria for the clinical trial, your doctor has a complete list of entry criteria that will be reviewed prior to study entry. For further information on eligibility criteria, please visit clinicaltrials.gov.

Select Inclusion Criteria - COPD

check.png

Age: 18 Years to 85 Years.

check.png

Physician-diagnosed COPD.

check.png

Current or former smoker with a history of smoking of ≥10 pack-years.

check.png

Body weight of ≥45 kg and BMI ≤45 kg/m2.

check.png

Must have experienced at least 1 COPD exacerbation requiring the use of systemic corticosteroids.

check.png

Current acute COPD exacerbation requiring an urgent healthcare visit for treatment.

Select Exclusion Criteria - COPD

cross.png

Regular use of immunosuppressive medication 12 weeks or 5 half-lives prior to approximately 12 weeks or 5 half-lives, whichever is longer.

cross.png

Unstable ischemic heart disease, cardiomyopathy, heart failure, uncontrolled hypertension. Cardiac arrhythmias including paroxysmal atrial fibrillation.

cross.png

Transient ischemic attack or stroke <6 months from Screening Visit; hospitalization for any cardiovascular or cerebrovascular event <6 months from Screening Visit.

cross.png

Female participant who is pregnant, lactating or breast-feeding.

cross.png

History of alcohol abuse and/or drug abuse.

cross.png

History of known immunodeficiency disorder or hepatitis B or C.

FAQs

  • Clinical research studies, also called clinical trials, are used to find out if a new medication works and if it's safe. These studies are run by qualified doctors, who take care of the people who choose to take part. Clinical research is a required step before any new drug can be approved by regulatory agencies, like FDA or EMA, and made available to the public.

     

    There are also independent groups — called Institutional Review Boards (IRBs) or Ethics Committees — that include both medical experts and non-medical people. Their job is to make sure participants are fully informed and protected throughout the study.

  • Informed consent is an important too to help you understand how your rights, safety, and well-being will be addressed throughout the clinical trial. During informed consent, you will be given all details about the study you are considering. This will include potential benefits and risks of the study. This information will help you decide whether you would like to participate.

     

    A member of the study team will walk you through the informed consent document and answer any questions you may have before you agree to participate and sign in. You can take as much times as you need to review it.

     

    While you are participating, the study team will tell you in a timely manner if new information is learned that could change your mind about continuing in the study. You can stop participating in the study at any time. Your decision will not affect your regular medical care or any benefits to which you are entitled.

  • As a participant in a clinical trial, you have many rights. Among them are the rights to:

     

    • Leave the study at any time

     

    • Ask questions about any aspect of the study

     

    • Understand the goal of the study and what you will be asked to do

     

    • Understand who will have access to information about you

     

    • Understand all of the risks and possible benefits of participating

     

    • Have your identify remain confidential

     

    • Understand how your identify is being protected

  • The study is xx weeks in duration, which includes xx weeks of assessment and xx weeks of safety follow-up.

  • An IRB, also known as an Independent Ethics Committee (IEC), is an independent group that includes scientists, doctors, and lay people. This group reviews a clinical trial's design and any updates to it, as well as any information provided to participants, to ensure that participant's rights, safety, and well-being are protected. IRBs and IECs have the authority to approved, ask for changes, or disapprove clinical research.

  • A DMC is typically made up of a group of external, independent experts who monitor any potential safety concerns that may develop during a clinical trial.

For additional information, please contact the Connect Biopharma Clinical Study Team:

clinical209@connectpharm.com

​

Rademikibart is an investigational agent that has not been approved for marketing by the U.S. Food and Drug Administration, the European Medicines Agency, or by any other regulatory agency.  Images do not depict actual trial participants.

Connect_Logo_CMYK.png
bottom of page